$3.99 +0.14 (3.64%) Vical Inc - NASDAQ

Aug. 26, 2016 | 04:00 PM
Last Trade: 3.99
Trade Time: Aug 26 04:00 PM Eastern Daylight Time
Change: +0.14 (3.64%)
Prev Close: 3.85
Open: 3.90
Bid: 3.90
Ask: 3.99
  1. No results found.
  1. CEOs Sell Vical, PhotoMedex, E.W. Scripps, Smart & Final Stores

    GuruFocus | Jan. 18, 2016 | 10:07AM EST
  2. Vical Posts Q1 Net Loss

    Benzinga | May. 8, 2015 | 07:51AM EST
  3. US Stock Futures Slip; JPMorgan Earnings In Focus

    Benzinga | Jan. 14, 2015 | 07:01AM EST
  4. US Stock Futures Edge Higher Ahead Of Retail Sales, Jobless Claims Data

    Benzinga | Dec. 11, 2014 | 07:01AM EST
  5. Vical Completes Enrollment In Its Therapeutic HSV-2 Vaccine Clinical Trial

    Benzinga | Dec. 11, 2014 | 06:32AM EST
  6. Events for the Week of Nov. 17-21, 2014

    Benzinga | Nov. 17, 2014 | 13:13PM EST
  7. Events Scheduled for Week of Jun 23rd to Jun 27th, 2014

    Benzinga | Jun. 23, 2014 | 18:25PM EST
  8. John Rogers Comments on Vical

    GuruFocus | Feb. 26, 2014 | 15:10PM EST
  9. Vical Announces Initiation of Phase 1/2 Trial of a Therapeutic HSV-2 Vaccine for Genital Herpes

    Benzinga | Dec. 17, 2013 | 07:05AM EST
  10. Stocks Hitting 52-Week Lows

    Benzinga | Dec. 16, 2013 | 10:35AM EST
  11. Kids Decide on Dolls or Devices - JAKK, Others 70% Off

    GuruFocus | Sep. 17, 2013 | 19:39PM EST
  12. UPDATE: Citigroup Lowers PT on Vical on Near-Term Challenges

    Benzinga | Aug. 14, 2013 | 10:37AM EST
  13. UPDATE: Credit Suisse Downgrades Vical Following Allovectin Program Termination

    Benzinga | Aug. 13, 2013 | 10:21AM EST
  14. UPDATE: Canaccord Genuity Downgrades Vical Following Allovectin Failure

    Benzinga | Aug. 13, 2013 | 09:32AM EST
  15. Benzinga's Top Downgrades

    Benzinga | Aug. 13, 2013 | 07:48AM EST
Trading Center